|
1
|
Phase II trial of consolidation docetaxel and samarium-153 in patients with bone metastases from castration-resistant prostate cancer.
|
J Clin Oncol
|
2009
|
1.83
|
|
2
|
Cancer of the penis.
|
Crit Rev Oncol Hematol
|
2005
|
1.39
|
|
3
|
Transcription factor E3 and transcription factor EB renal cell carcinomas: clinical features, biological behavior and prognostic factors.
|
J Urol
|
2010
|
1.16
|
|
4
|
Docetaxel reintroduction in patients with metastatic castration-resistant docetaxel-sensitive prostate cancer: a retrospective multicentre study.
|
BJU Int
|
2010
|
1.13
|
|
5
|
Chemotherapy in patients with teratoma with malignant transformation.
|
Eur Urol
|
2006
|
1.03
|
|
6
|
'Burned-out' primary testicular cancer.
|
BJU Int
|
2004
|
1.01
|
|
7
|
Advanced seminoma--treatment results and prognostic factors for survival after first-line, cisplatin-based chemotherapy and for patients with recurrent disease: a single-institution experience in 145 patients.
|
Cancer
|
2003
|
1.00
|
|
8
|
Mixed nonseminomatous germ cell tumor presenting as a subcutaneous tissue mass.
|
Am J Dermatopathol
|
2006
|
0.88
|
|
9
|
Treatment of visceral, unresectable, or bulky/unresectable regional metastases of penile cancer.
|
Urology
|
2010
|
0.87
|
|
10
|
Germ cell tumors. Case 3. Primary yolk sac tumor of the liver.
|
J Clin Oncol
|
2004
|
0.86
|
|
11
|
A phase III trial of docetaxel-estramustine in high-risk localised prostate cancer: a planned analysis of response, toxicity and quality of life in the GETUG 12 trial.
|
Eur J Cancer
|
2011
|
0.85
|
|
12
|
[Urothelial tumors].
|
Prog Urol
|
2007
|
0.81
|
|
13
|
Perivesical fat invasion in bladder cancer: implications for prognosis comparing pT2b, pT3a and pT3b stages and consequences for adjuvant chemotherapy indications.
|
BJU Int
|
2012
|
0.80
|
|
14
|
Larotaxel with Cisplatin in the first-line treatment of locally advanced/metastatic urothelial tract or bladder cancer: a randomized, active-controlled, phase III trial (CILAB).
|
Oncology
|
2013
|
0.77
|
|
15
|
Bladder-conserving surgery and interstitial brachytherapy for lymph node negative transitional cell carcinoma of the urinary bladder: results of a 28-year single institution experience.
|
Radiother Oncol
|
2004
|
0.77
|
|
16
|
Uncommon malignancies: case 3. Paratesticular desmoplastic small round-cell tumor.
|
J Clin Oncol
|
2005
|
0.77
|
|
17
|
Germ cell tumors. Case 2. Unusual course of pure testicular seminoma.
|
J Clin Oncol
|
2004
|
0.75
|
|
18
|
[Urothelial tumors].
|
Prog Urol
|
2004
|
0.75
|
|
19
|
[Upper urinary tract tumor: conservative treatment of localized forms].
|
Prog Urol
|
2003
|
0.75
|
|
20
|
[Follow-up of urothelial tumours. Guidelines of the Comité de Cancérologie de l'Association Française d'Urologie].
|
Prog Urol
|
2005
|
0.75
|
|
21
|
FDG PET/CT findings in secondary hyperparathyroidism not mimicking multiple bone metastases.
|
Eur J Nucl Med Mol Imaging
|
2008
|
0.75
|